Toxicity of inorganic vanadium compounds

Research on Chemical Intermediates

Volumn 41, Issue 7, 2015, Pages 4873-4897

  Ghosh, Sumanta K ^a   Saha, Rumpa ^a   Saha, Bidyut ^a  

^a UNIVERSITY OF BURDWAN   (India)

Author keywords

Embryotoxicity; Pharyngitis; Teratogenicity; Vanadium

Indexed keywords

BLOOD; VANADIUM;

BIOCHEMICAL CHANGES; BODY WEIGHT; EMBRYOTOXICITY; PHARYNGITIS; PULMONARY HEMORRHAGE; SIDE EFFECT; TERATOGENICITY; TOXIC EFFECT;

VANADIUM COMPOUNDS;

EID: 84932197030     PISSN: 09226168     EISSN: 15685675     Source Type: Journal    
DOI: 10.1007/s11164-014-1573-1     Document Type: Article

References (121)

1. A.M. Evangelou, Vanadium in cancer treatment. Crit. Rev. Oncol. Hematol. 42, 246-265 (2002)
2. J.L. Domingo, Vanadium and tungsten derivatives as antidiabatic agents. Biol. Trace Elem. Res. 88, 97-112 (2002)
3. S.M. Brichard, J.C. Henquin, The role of vanadium on management of diabetis. TIPS 16, 265-270 (1995)
4. A.M. Morgan, O.S. El-Tawil, Effects of ammonium metavanadate on fertility and reproductive performance of adult male and female rats. Pharmacol. Res. 47, 75-85 (2003)
5. L. Wang, D. Medan, R. Mercer, D. Overmiller, S.S. Leonard, V. Castranova, V. Shi, M. Ding, C. Huang, Y. Rajanasakul, Vanadium induced apoptosis and pulmonary inflammation in mice. Role of reactive oxygen species. J. Cell. Physiol. 195, 99-107 (2003)
6. J.L. Domingo, M. Gomez, D.J. Sanchez, J.M. Llobet, C.L. Keen, Toxicity of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation. Mol. Cell. Biochem. 153, 233-240 (1995)
7. H. Lia, D. Zhoua, Q. Zhanga, C. Fengb, W. Zhengc, K. Heb, Y. Lana, Vanadium exposure-induced neurobehavioral alterations among Chinese workers. Neuro Toxicol. 36, 49-54 (2013)
8. T.I. Fortoul, G. Piñón-Zarate, M.E. Diaz-Bech, A. González-Villalva, P. Mussali-Galante, V. Rodriguez-Lara, L. Colin-Barenque, M. Martinez-Pedraza, L.F. Montaño, Spleen and bone marrow megakaryocytes as targets for inhaled vanadium. Histol. Histopathol. 23, 1321-1326 (2008)
9. M.C. Cam, R.A. Pederson, R.W. Brownsey, J.H. MeNeill, Long term effectiveness of vanadyl sulphate in streptozotocin-diabetic rats. Diabetologia 36, 218-224 (1993)
10. S. Dai, J.H. MeNeill, One year treatment of non diabetic and streptozotocin-diabetic rats with vanadyl sulphate did not alter blood pressure or hematological indices. Pharmacol. Toxicol. 74, 110-115 (1994)
11. J. Somerville, B. Davis, Effect of vanadium on cerum cholesterol. Am. Heart J. 64, 54-56 (1962)
12. J.B. Faweett, S.J. Farquhar, T. Thou, B.I. Shand, Oral vanadyl sulphate does not affect blood cells, viscosity or biochemistry in humans. Thermacol. Toxicol. 80, 202-206 (1997)
13. B. Boulassela, N. Sadegb, O. Rousselc, M. Perrinc, H. Belhadj-Tahard, Fatal poisoning by vanadium. Forensic Sci. Int. 206, e79-e81 (2011)
14. Y. Zhaoa, L. Yeb, H. Liub, Q. Xiab, Y. Zhangb, X. Yanga, K. Wangb, Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress. J. Inorg. Biochem. 104, 371-378 (2010)
15. D.J. Sanchez, M.T. Colomina, J.L. Domingo, J. Corbella, Prevention by sodium 4,5-dihydroxy benzene-1,3-disulphonate (titron) of vanadate induced behavioral toxicity in rats. Biol. Trace Elem. Res. 69, 249-258 (1999)
16. K.H. Thompson, Y. Tsukada, Z. Xu, M.L. Batell, J.H. McNeill, C. Orvig, Influence of chelation and oxidation state of vanadium bioavailability and their effects on tissue connection of zinc, copper and iron. Biol. Trace Elem. Res. 96, 31-44 (2002)
17. T. Storr, D. Mitchell, P. Buglyo, K.H. Thompson, V.G. Yuen, J.H. McNeill, C. Orvig, Vanadyl-tizolidinedione combination agents or diabetes therapy. Bioconjugate Chem. 14, 212-221 (2003)
18. A.G. Thompson, R.M. Strieter, I. Lindley, K.D. Bellman, I.A. Setyawati, B.O. Patrik, V. Karunaratne, G. Rawji, J. Weeler, K. Sutton, C. Cassity, J.H. McNeill, V.G. Yuen, C. Orvig, Preparation and characterization of vanadyl complexes with bidentate malton-type ligands; in vivo comparisons of anti-diabetic therapeutic potential. J. Biol. Inorg. Chem. 8, 66-74 (2003)
19. A.V. Roschin, E.K. Ordzhonikidze, V. Shalganova, Toxicity, metabolism, carrer state. J. Hyg. Epidemiol. Microbiol. Immunol. 24, 377-383 (1980)
20. T. Kawai, K. Seiji, T. Watanabe, H. Nakatsuka, M. Ikeda, Urinary vanadium as a biological indicator of exposure to vanadium. Int. Arch. Occup. Environ. Health 61, 283-287 (1989)
21. Faulkner-Hudson T.G. 1964
22. J.M. Llobet, J.L. Domingo, Acute toxicity of vcanadium compounds in rats and mice. Toxicol. Lett. 23, 227-231 (1984)
23. M.A. Altamirano-Lozano, L. Álvarez-Barrera, R.A. Mateos-Nava, T.I. Fortoul, J.J. Rodríguez-Mercado, Potential for Genotoxic and Reprotoxic Effects OF Vanadium Compounds due to Occupational and Environmental Exposures: An Article Based on a Presentation at the 8th International Symposium on Vanadium Chemistry, Biological Chemistry, and Toxicology, Washington DC, Aug 15-18, 2012, Posted online on May 10, 2013. doi: 10.3109/1547691X.2013.791734
24. Assem F.L. Levy L.S. Michibata H. 2012
25. M.J. Hosseini, F. Shaki, M. Ghazi-Khansari, J. Pourahmad, Toxicity of vanadium on isolated rat liver mitochondria: a new mechanistic approach. Metallomics 5, 152-166 (2013)
26. P.G. Smith, C. Boutin, L.A. Knopper, Vanadium pentoxide phytotoxicity: effect of species selection and nutrient concentration. Environ. Contam. Toxicol. 64, 87-96 (2013)
27. J.L. Domingo, J.M. Llobet, J.M. Tomas, J. Corbella, Short term toxicity studies of vanadium in rats. J. Appl. Toxicol. 5, 418-421 (1984)
28. H. Zaporowska, W. Wasilewski, Some selected peripheral blood and haemopoietic system indices Wister rats with chronic vanadium intoxication. Comp. Biochem. Physiol. 93C, 175-180 (1989)
29. C. Castellinia, E. Mourvakia, B. Sartinib, R. Cardinalia, E. Morettib, G. Collodelb, S. Fortanerc, E. Sabbionic, T. Renierib, In vitro toxic effects of metal compounds on kinetic traits and ultrastructure of rabbit spermatozoa. Reprod. Toxicol. 27, 46-54 (2009)
30. M. Mishra, R. Mathur, R.K. Gautam, Therapeutic application of some chelating agents against intoxication of Vanadium compounds in the reproductive organs of male rats. Glob. Adv. Res. J. Microbiol. 2, 017-021 (2013)
31. F.L. Assem, L.S. Levy, A review of current toxicological concerns on vanadium pentoxide and other vanadium compounds: gaps in knowledge and directions for future research. J. Toxicol. Environ. Health 12, 289-306 (2009)
32. P.D. Greg, R.G. Murray, Chemistry and association of vanadium compounds in heavy oil and bitumen, and implications for their selective removal. Energy Fuels 24, 2795-2808 (2010)
33. Parkes W.R. 1994
34. M. Kiviluoto, O. Rasanen, A. Rinne, M. Rissanen, Effects on the respiratory tract of workers in a vanadium factory. Scand. J. Work Environ. Health 5, 50-589 (1979)
35. M. Kiviluoto, L. Pyy, A. Pakarinen, Clinical laboratory results of vanadium - exposed workers. Arch. Environ. Health 36, 109-113 (1980)
36. J.D. Boice, M.T. Mumma, W.J. Blot, Cancer and noncancer mortality in populations living near uranium and vanadium mining and milling operations in Montrose County, Colorado, 1950-2000. Radiat. Res. 167, 711-7126 (2007)
37. National Toxicology Program. 2002. Technical report on the studies of vanadium pentoxide (CAS no. 1314-62-1) in F344/N rats and B6C3F1 mice (inhalation studies). NTP TR 507. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Toxicology Program, Research Triangle Park, NC
38. F.L. Assem, L.S. Levy, A review of current toxicological concerns on vanadium pentoxide and other vanadium compounds: gaps in knowledge and directions for future research. J. Toxicol. Environ. Health. Part B. 12(4) 2009
39. IARC, Cobalt in Hard Metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide, IARC Monogr. Eval. Carcinogen. Risks Hum., pp. 227-292. Lyon, IARC Press. 86, 227-292 (2006)
40. Scientific Committee on Occupational Exposure Limits, Recommendation From Scientific Committee on Occupational Exposure Limit for Vanadium Pentoxide (2004). SCOEL/SUM/62H. EC, Luxembourg
41. American Conference of Governmental Industrial Hygienists, Vanadium Pentoxide, pp. 1-9. In Documentation of the threshold limit values and biological exposure indices, 7th edn. (ACGIH, 2009)
42. Greenwood N.N. Earnshaw A. 1989
43. Greenwood N.N. Earnshaw A. 1989
44. Greenwood N.N. Earnshaw A. 1989
45. J.L. Domingo, M. Gomez, J.M. Llobet, J. Corbella, C.L. Keen, Oral vanadium administration to streptozotocine-diabetic rats has marked negative side-effects which are independent of the form of vanadium used. Toxicology 66, 279-287 (1991)
46. B.S. Jandhyala, G.J. Hom, Physiological and pharmacological properties of vanadium. Life Sci. 33, 1325-1340 (1983)
47. L.C. Cantely, L. Josephson, M. Warner, C. Yanagisawa, C. Lechen, G. Guidotti, Vanadate is a potent (NaK)ATPase inhibitor found in ATP derived from muscle. J. Biol. Chem. 252, 7421-7423 (1977)
48. B.R. Nechay, Mechanism of action of vanadium. Annu. Rev. Pharmacol. Toxicol. 24, 501-524 (1984)
49. B.R. Nechay, J.P. Saunders, Inhibition by vanadium of sodium and potassium dependent adenosinetriphosphatase derived from animal and human tissues. J. Environ. Pathol. Toxicol. 2, 247-262 (1978)
50. R. Crebelli, P. Leopardi, Long-term risks of metal contaminants in drinking water: a critical appraisal of guideline values for arsenic and vanadium. Ann. Ist. Super Sanità. 48, 354-361 (2012)
51. C.E. Heyliger, A.G. Tahiliani, J.H. McNeill, Effects of vanadates on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 277, 1474-1477 (1985)
52. J. Meyerovitch, Z. Farfel, J. Sack, Y. Shechter, Oral administration of vanadates normalizes blood glucose level in streptozotocin-treated rats. J. Biol. Chem. 262, 6658-6662 (1991)
53. D.J. Paulson, S.J. Kopp, J.P. Tow, D.G. Peace, Effects of vanadate on in vivo myocardial reactivity to norepinephrine in diabetic rats. J. Pharmacol. Exp. Ther. 240, 529-534 (1987)
54. S.M. Bichard, W. Okitolonda, J.C. Henquin, Long term impruvment of glucose homeostasis by vanadate treatment in diabetic rats. Endocrinology 123, 2048-2053 (1989)
55. J. Gil, M. Miralpeix, J. Carreras, R. Bartrons, Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats. J. Biol. Chem. 263, 1868-1871 (1988)
56. M. Bendayn, D. Gingras, Effects of vanadate administration on blood glucose and insuline level as well as on the exocrine pancrietic function in streptozotocine-deabetic rats. Diabetologia 32, 561-567 (1989)
57. S. Pugazhenthi, R.L. Khandelwl, insuline like effects of vanadate on hepatic glycogen metabolism in nondiabetic and streptozotocine-induced diabetic rats. Diabetes 39, 821-827 (1990)
58. J.J. Mongold, G.H. Cros, L. Vian, A. Tep, S. Ramanadham, G. Siou, J. Diaz, J.H. Mcneill, J.J. Serrano, Toxicological aspects of vanadyl sulphate, SDS on diabetic rats: effect of vanadium levels and pancreatic beta-cell morphology. Pharamcol. Toxicol. 67, 192-198 (1994)
59. J.L. Domongo, A. Ortega, J.M. Llobet, C.L. Keen, No inpruvment of glucose homeostasis in diabetic rats by vanadate treatment when given by gavage. Trace Elem. Med. 8, 181-186 (1991)
60. J.L. Domingo, D.J. Sanchez, M. Gomez, J.M. Llobet, J. Corbella, Administration of vanadyl sulphate by gavage does not normalize blood glucose levels in streptozotocine- induced diabetic rats. Res. Commun. Chem. Pathol. Pharmacol. 75, 369-372 (1992)
61. Commission of the European Communities, Methodology for the derivation of occupational exposure limits: key documentation.EUR 19253 EN. (Commission of the European Communities, Brussels, 1999)
62. Health and Safety Executive, Vanadium and its organic compounds: Risk assessment document. EH72/15. (HMSO, Norwich, HSE, 2002)
63. Deutsche Forschungsgemeinschaft, Vanadium and its inorganic compounds. Draft report. Occupational Toxicants and MAK values. (Wiley, Weinheim, 2007)
64. V.A. Ehrlich, A.K. Nersesyan, S. Knasmüller, Inhalative exposure to vanadium pentoxide causes DNA damage in workers: results of a multiple end point study. Environ. Health Perspect 116, 1689-1693 (2008)
65. J.J. Rodríguez-Mercado, R.A. Mateos-Nava, M.A. Altamirano-Lozano, DNA damage induction in human cells exposed to vanadium oxides in vitro. Toxicol. Vitro 25, 1996-2002 (2011)
66. J.A. Dill, K.M. Lee, K.H. Mellinger, D.J. Bates, L.T. Burka, J.H. Roycroft, Lung deposition and clearance of inhaled vanadium pentoxide in chronically exposed F344 rats and B6C3F1 mice. Toxicol. Sci. 77, 6-18 (2004)
67. J.H. Duffus, Carcinogenicity classification of vanadium pentoxide and inorganic vanadium compounds, the NTP study of carcinogenicity of inhaled vanadium pentoxide, and vanadium chemistry. Regul. Toxicol. Pharmacol. 47, 110-114 (2007)
68. N.B. Ress, B.J. Chou, R.A. Renne, J.A. Dill, R.A. Miller, J.H. Roycroft, J.R. Hailey, J.K. Haseman, J.R. Bucher, Carcinogenicity of inhaled vanadium pentoxide in F344/N rats and B6C3F1 mice. Toxicol. Sci. 74, 287-296 (2003)
69. P. Holko, J. Ligęza, J. Kisielewska, A.M. Kordowiak, A. Klein, The effect of vanadyl sulphate (VOSO4) on autocrine growth of human Epithelial cancer cell lines. Pol. J. Pathol. 59(1), 3-8 (2008)
70. M. Rojas-Lemus, M. Altamirano-Lozano, T. I. Fortoul, Sex differences in blood genotoxic and cytotoxic effects as a consequence of vanadium inhalation: micronucleus assay evaluation. J. Appl. Toxicol. (26 APR 2013, doi: 10.1002/jat.2873)
71. G.N. Rao, New diet (NTP-2000) for rats in the National Toxicology Program toxicity and carcinogenicity studies. Fundam. Appl. Toxicol. 32, 102-108 (1996)
72. G.N. Rao, New nonpurified diet (NTP-2000) for rodents in the National Toxicology Program's toxicology and carcinogenesis studies. J. Nutr. 127, 842S-846S (1997)
73. F. Geyikoglu, Boron compounds reduce vanadium tetraoxide genotoxicity in human lymphocytes. Environ. Toxicol. Pharmacol. 26, 342-347 (2008)
74. U. Heinrich, R. Fuhst, R. Rittinghausen, O. Creutzenberg, B. Bellmann, W. Koch, K. Levsen, Chronic inhalation exposure of Wistar rats and two different strains of mice to diesel exhaust, carbon black, and titanium dioxide. Inhal. Toxicol. 7, 533-556 (1995)
75. Z. Zhang, Y. Wang, H.G. Vikis, L. Johnson, G. Liu, J. Li, M.W. Anderson, R.C. Sills, H.L. Hong, T.R. Devereux, T. Jacks, K.L. Guan, M. You, Wild type Kras2 can inhibit lung carcinogenesis in mice. Nat. Genet. 29, 25-33 (2001)
76. D.C. Crans, J.J. Smee, E. Gaidamauskas, L. Yang, The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. Chem. Rev. 104, 849-902 (2004)
77. M. Aureliano, R.M.C. Gândara, Decavanadate effects in biological systems. J. Inorg. Biochem. 99, 979-985 (2005)
78. B. Mukherjee, B. Patra, S. Mahapatra, P. Banerjee, A. Tiwari, M. Chatterjee, Vanadium - an element of atypical biological significance. Toxicol. Lett. 150, 135-143 (2004)
79. M. Valko, H. Morris, M.T. Cronin, Metals, toxicity and oxidative stress. Curr. Med. Chem. 12, 1161-1208 (2005)
80. L.M. Pierce, F. Alessandrini, J.J. Godleski, J.D. Paulauskis, Vanadium-induced chemokine mRNA expression and pulmonary inflammation. Toxicol. Appl. Pharmacol. 138, 1-11 (1996)
81. M. Valko, C.J. Rhodes, J. Moncol, M. Izakovic, M. Mazur, Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160, 1-40 (2006)
82. H. Sakurai, Vanadium distribution in rats and DNA cleavage by vanadyl complex: implication for vanadium toxicity and biological effects. Environ. Health Perspect 102(suppl. 3), 35-36 (1994)
83. J. Li, G. Elberg, D.C. Crans, Y. Shechter, Evidence for the distinct vanadyl(+4)-dependent activating system for manifesting insulin-like effects. Biochemistry 35, 8314-8318 (1996)
84. G. Huyer, S. Liu, J. Kelly, J. Moffat, P. Payette, B. Kennedy, G. Tsaprailis, M.J. Gresser, C. Ramachandran, Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate. J. Biol. Chem. 272, 843-851 (1997)
85. N. Kilibardaa, S.E. Aftonb, J.M. Harringtonb, F. Yana, K.E. Levineb, Rapid speciation and determination of vanadium compounds using ion-pair reversed-phase ultra-high-performance liquid chromatography inductively coupled plasma-sector field mass spectrometry. J. Chromatogr. A (2013). doi: 10.1016/j.chroma.2013.06.074
86. J.M. Wörle-Knirsch, K. Kern, C. Schleh, C. Adelhelm, C. Feldmann, H.F. Krug, Nanoparticulate vanadium oxide potentiated vanadium toxicity in human lung cells. Environ. Sci. Technol. 41, 331-336 (2007)
87. L. Andrezálováa, H. Gbelcováb, Z. ɰuračkováa, DNA damage induction and antiproliferative activity of vanadium(V) oxido monoperoxido complex containing two bidentate heteroligands. J. Trace Elem. Med. Biol. 27, 21-26 (2013)
88. K. Wozniak, J. Blasiak, Vanadyl sulfate can differentially damage DNA in human lymphocytes and HeLa cells. Arch. Toxicol. 78, 7-15 (2004)
89. X. Shi, H. Jiang, Y. Mao, J. Ye, U. Saffiotti, Vanadium(IV)-mediated free radical generation and related 2′-deoxyguanosine hydroxylation and DNA damage. Toxicology 106, 27-38 (1996)
90. X. Shi, P. Wang, H. Jiang, Y. Mao, N. Ahmed, N. Dalal, Vanadium(IV) causes 2′-deoxyguanosine hydroxylation and deoxyribonucleic acid damage via free radical reactions. Ann. Clin. Lab. Sci. 26, 39-49 (1996)
91. S. Ivancsits, A. Pilger, E. Diem, A. Schaffer, H.W. Rüdiger, Vanadate induces DNA strand breaks in cultured human fibroblasts at doses relevant to occupational exposure. Mutat. Res. 519, 25-35 (2002)
92. E. Rojas, M. Valverde, L.A. Herrera, M. Altamirano-Lozano, P. Ostrosky-Wegman, Genotoxicity of vanadium pentoxide evaluate by the single cell gel electrophoresis assay in human lymphocytes. Mutat. Res. Environ. Mutagen. Relat. Subj. 359, 77-84 (1996)
93. N. Kleinsasser, P. Dirschedl, R. Staudenmaier, U. Harréus, B. Wallner, Genotoxic effects of vanadium pentoxide on human peripheral lymphocytes and mucosal cells of the upper aerodigestive tract. Int. J. Environ. Health Res. 13, 373-379 (2003)
94. L.S. Capella, M.R. Gefé, E.F. Silva, O. Affonso-Mitidieri, A.G. Lopes, V.M. Rumjanek, M.A. Capella, Mechanisms of vanadate-induced cellular toxicity: role of cellular glutathione and NADPH. Arch. Biochem. Biophys. 406, 65-72 (2002)
95. S. Mena, A. Ortega, J.M. Estrela, Oxidative stress in environmental-induced carcinogenesis. Mutat. Res. 674, 36-44 (2009)
96. D.P. Gibson, R. Brauninger, H.S. Shaffi, G.A. Kerckaert, R.A. LeBoeuf, R.J. Isfort, M.J. Aardema, Induction of micronuclei in Syrian hamster embryo cells: comparison to results in the SHE cell transformation assay for national toxicology program test chemicals. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 392, 61-70 (1997)
97. S.M. Attia, O.A. Badary, F.M. Hamada, M.H. de Angelis, I.D. Adler, Orthovanadate increased the frequency of aneuploid mouse sperm without micronucleus induction in mouse bone marrow erythrocytes at the same dose level. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 583, 158-167 (2005)
98. R. Ciranni, M. Antonetti, L. Migliore, Vanadium salts induce cytogenetic effects in in vivo treated mice. Mutat. Res. Genet. Toxicol. 343, 53-60 (1995)
99. P. Leopardi, P. Villani, E. Cordelli, E. Siniscalchi, E. Veschetti, R. Crebelli, Assessment of the in vivo genotoxicity of vanadate: analysis of micronuclei and DNA damage induced in mice by oral exposure. Toxicol. Lett. 158, 39-49 (2005)
100. P. Villani, E. Cordelli, P. Leopardi, E. Siniscalchi, E. Veschetti, A.M. Fresegna, R. Crebelli, Evaluation of genotoxicity of oral exposure to tetravalent vanadium in vivo. Toxicol. Lett. 170, 11-18 (2007)
101. J.B. Mailhes, C. Hilliard, J.W. Fuseler, S.N. London, Vanadate, an inhibitor of tyrosine phosphatases, induced premature anaphase in oocytes and aneuploidy and polyploidy in mouse bone marrow cells. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 538, 101-107 (2003)
102. T. Chakraborty, A. Chatterjee, D. Dhachinamoorthi, S. Srivastawa, L. Panayappan, M. Chatterjee, Vanadium limits the expression of proliferating cell nuclear antigen and inhibits early DNA damage during diethylnitrosamine-induced hepatocellular preneoplasia in rats. Environ. Mol. Mutagen. 4, 603-615 (2006)
103. T. Chakraborty, A. Chatterjee, M.G. Saralaya, D. Dhachinamoorthi, M. Chatterjee, Vanadium inhibits the development of 2-acetylaminofluorene-induced premalignant phenotype in a two-stage chemical rat hepatocarcinogenesis model. Life Sci. 78, 2839-2851 (2006)
104. P. Ramírez, D.A. Eastmond, J.P. Laclette, P. Ostrosky-Wegman, Disruption of microtubule assembly and spindle formation as amechanism for the induction of aneuploid cells by sodium arsenite and vanadium pentoxide. Mutat. Res. Rev. Mutat. Res. 386, 291-298 (1997)
105. A. Glaviano, V. Nayak, E. Cabuy, D.M. Baird, Z. Yin, R. Newson, D. Ladon, M.A. Rubio, P. Slijepcevic, F. Lyng, C. Mothersill, C.P. Case, Effects of hTERT on metal ion-induced genomic instability. Oncogene 25, 3424-3435 (2006)
106. Z. Zhang, C. Huang, J. Li, X. Shi, Vanadate-induced cell growth arrest is p53-dependent through activation of p21 in C141cells. J. Inorg. Biochem. 89, 142-148 (2002)
107. Z. Zhang, N. Gao, H. He, C. Huang, J. Luo, X. Shi, Vanadate activated Akt and promoted S phase entry. Mol. Cell Biochem. 255, 227-237 (2004)
108. Z. Zhang, H. He, F. Chen, C. Huang, X. Shi, MAPKs mediate S phase arrest induced by vanadate through a p53-dependent pathway in mouse epidermal C141 cells. Chem. Res. Toxicol. 15, 950-956 (2002)
109. W. Yi-Zhe, C.B. James, Mechanism of extracellular signal-regulated kinase (ERK)-1 and ERK-2 activation by vanadium pentoxide in rat pulmonary myofibroblasts. Am. J. Respir. Cell Mol. Biol. 22, 590-596 (2000)
110. T.R. Devereux, W. Holliday, C. Anna, N. Ress, J. Roycroft, R.C. Sills, Map kinase activation correlates with k-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years. Carcinogenesis 23, 1737-1743 (2002)
111. M. Lee, J. Hwang, H. Yun, E.J. Kim, M.J. Kim, S.S. Kim, J. Ha, Critical roles of AMP-activated protein kinase in the carcinogenic metal-induced expression of VEGF and HIF-1 proteins in DU145 prostate carcinoma. Biochem. Pharmacol. 72, 91-103 (2006)
112. C.L.J. Parfett, R. Pilon, Oxidative stress-regulated gene expression and promotion of morphological transformation induced in C3H/10T1/2 cells by ammonium metavanadate. Food Chem. Toxicol. 33, 301-308 (1995)
113. A.C.G. Freire, H. Aoyama, M. Haun, C.V. Ferreira, Relationship between phosphatase activity and cytotoxic effect of two protein phosphatase inhibitors, okadaic acid and pervanadate, on human myeloid leukemia cell line. J. Enzyme Inhib. Med. Chem. 18, 425-429 (2003)
114. H.A. Ngwa, A. Kanthasamya, V. Anantharama, C. Songa, T. Witteb, R. Houkb, A.G. Kanthasamy, Vanadium induces dopaminergic neurotoxicity via protein kinase Cdelta dependent oxidative signaling mechanisms: relevance to etiopathogenesis of Parkinson's disease. Toxicol. Appl. Pharmacol. 240, 273-285 (2009)
115. J. Ye, M. Ding, X. Zhang, Y. Rojanasakul, S. Nedospasov, V. Vallyathan, V. Castranova, X. Shi, Induction of TNFalpha in macrophages by vanadate is dependent on activation of transcription factor NF-kappaB and free radical reactions. Mol. Cell Biochem. 198, 193-200 (1999)
116. Z. Li, J. Stonehuerner, R.B. Devlin, Y.C. Huang, Discrimination of vanadium from zinc using gene profiling in human bronchial epithelial cells. Environ. Health. Perspect. 113, 1747-1754 (2005)
117. Y.-C.T. Huang, W. Wu, A.J. Ghio, J.D. Carter, R. Silbajoris, R.B. Devlin, J.M. Samet, Activation of EGF receptors mediates pulmonary vasoconstriction induced by residual oil fly ash. Exp. Lung Res. 28, 19-38 (2002)
118. J.C. Bonner, A.B. Rice, J.L. Ingram, C.R. Moomaw, A. Nyska, A. Bradbury, A.R. Sessoms, P.C. Chulada, D.L. Morgan, D.C. Zeldin, R. Langenbach, Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. Am. J. Pathol. 161, 459-470 (2002)
119. M.E. Klein-Patel, G. Diamond, M. Boniotto, S. Saad, L.K. Ryan, Inhibition of beta-defensin gene expression in airway epithelial cells by low doses of residual oil fly ash is mediated by vanadium. Toxicol. Sci. 92, 115-125 (2006)
120. E.A. Knecht, W.J. Moorman, J.C. Clark, R.D. Hull, R.E. Biagini, D.W. Lynch, T.J. Boyle, S.D. Simon, Pulmonary reactivity to vanadium pentoxide following subchronic inhalation exposure in a non-human primate animal model. J. Appl. Toxicol. 12, 427-434 (1992)
121. S.K. Pandey, J.-F. Théberge, M. Bernier, M., A.K. Srivastava. Phsophatidylinositol 3-kinase requirement in activation of the ras/C-raf/MEK/ERK and p70s6k signaling cascade by the insulinomimetic agent vanadyl sulfate. Biochemistry 38, 14667-14675 (1999)